Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System
K-Number: K182687 · 2018-11-23
ApplicantAccuray Incorporated
Decision Date2018-11-23
Product CodeIYE
Advisory CommitteeRA
DecisionSubstantially Equivalent
Device Summary
Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System is a medical device manufactured by Accuray Incorporated. It received FDA 510(k) clearance on 2018-11-23 under approval number K182687. The device is classified under product code IYE. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System?
Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System is a medical device that received FDA 510(k) clearance on 2018-11-23. It is manufactured by Accuray Incorporated. The 510(k) number is K182687.
When was Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System approved by the FDA?
Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System received FDA 510(k) clearance on 2018-11-23, under approval number K182687.
What company makes Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System?
Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System is manufactured by Accuray Incorporated.
What is the FDA product code for Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System?
The FDA product code for Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System is IYE.
Related Clinical Trials
NCT07614997
Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck
NOT_YET_RECRUITING
NCT07194317
A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment
COMPLETED
NCT05003843
BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis
ACTIVE_NOT_RECRUITING
NCT07499128
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
ENROLLING_BY_INVITATION
NCT07517172
Evaluating Noninvasive Brain Stimulation for TMD Pain: A Feasibility Study
RECRUITING
NCT03280862
DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS
COMPLETED
Related PubMed Literature
PMID: 39670276
Multicenter Evaluation of Machine-Learning Continuous Pulse Rate Algorithm on Wrist-Worn Device.
Digital biomarkers (2024)
PMID: 38767890
Strengthening the use of artificial intelligence within healthcare delivery organizations: balancing regulatory compliance and patient safety.
Journal of the American Medical Informatics Association : JAMIA (2024)
PMID: 37948287
TCCC Decision Support With Machine Learning Prediction of Hemorrhage Risk, Shock Probability.
Military medicine (2023)
PMID: 35685299
Multicenter, Double-Blinded, Randomized, Active-Sham Controlled Clinical Study Design to Assess the Safety and Effectiveness of a Novel High Frequency Electric Nerve Block System in the Treatment of Post-Amputation Pain (The QUEST Study).
Journal of pain research (2022)
Other Devices by Accuray Incorporated
Related Devices (Code: IYE)
K162476Varian High Energy Linear AcceleratorVarian Medical Systems, Inc.
K161400ImagingRing SystemMedphoton GmbH
K162468ClearCheckRadformation
K162355Raycast MammoRx Carbon Fibre Breast BoardOrfit Industries NV
K162577Dosimetry Check Version 5 Release 1Math Resolutions, LLC
K162265CushionCast Moldable CushionsIzi Medical Products, LLC
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.